Ken Sall

Ken is leading the clinical development of ALY688 Ophthalmic Solution. He is a Board-Certified Ophthalmologist and was formerly the Medical Director of the Sall Research Medical Center in Southern California. In that capacity, he has been a Principal Investigator for over 200 clinical trials specializing in all eye indications, including many studies on dry eye disease. Ken graduated from the University of Southern California School of Medicine and completed an ophthalmology residency at the University of California, San Diego. He has also completed a fellowship in cornea and external eye disease.